Buy reiterated with a $196 price target after blowout Q2 2026 earnings, raised guidance, and 60%+ margins—read now.
Dine Brands Global reported Q2 2026 revenue above expectations, but EPS and adjusted EPS missed analyst estimates. Read more ...
OXLCM CEF's 8.25% term preferred offers high monthly income, strong protections, and improved security after OXLC ...
Everus Construction Group delivered a standout Q2 2026, with GAAP EPS of $1.64, beating estimates by 44% and driving the ...
Joby Aviation Q2 earnings: revenue beats on Blade growth as eVTOL certification advances; 2026 passenger target and raised ...
Schwab US Dividend Equity ETF may offer a safer way to keep diversified equity exposure amid macro risk. Click here to read ...
DIVO's selective covered call strategy targets only 20–30% of holdings, preserving capital appreciation. Read why DIVO ETF is ...
July 2026 was a flattish month for markets. On our machine learning forecasting models, we see asset class after asset class ...
Rigel Pharmaceuticals in-licensed Veppanu, a drug for the treatment of certain breast cancer patients, targeting a $1B market ...
High-yield bonds advanced in the second quarter as geopolitical tensions eased, helping stabilize energy prices and temper ...
The Madison Small Cap Fund returned 12.7% in Q2 2026, trailing benchmarks as tech and healthcare sectors surged. Read the ...
Braskem (BAK) faces default risk, leverage and liquidity stress, and likely equity wipeout amid industry headwinds. Read here ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results